G6PD and G6PD deficiency: Primaquine is the only drug currently licensed for the radical cure of P. vivax; however, it can cause severe hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common genetic disorder [8] that is positively associated with P. vivax incidence [9].